Henry Govekar, MD
Colon & Rectal Surgery · Elmwood Park, ILNPI 1417121872
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,500 of the $15,361 with a category attached, or 68.4%. Intuitive Surgical accounts for 89.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $10,917 and has fallen 90.0% since, to $1,092 in 2025.
Across 90 payments — averaging $170.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Medrobotics Inc.$386
- Medtronic$329
- Baxter Healthcare$314
- Innovation Technologies Inc$153
- Medical Device Business Services, Inc.$138
- plus $336 from 7 others
What the payments were for
- Consulting fees$801%
- Travel & lodging$1,68411%
- Food & beverage$3,09720%
- Education$10,50068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 71 | $13,706 |
| Medrobotics Inc. | 1 | $386 |
| Medtronic | 4 | $329 |
| Baxter Healthcare | 3 | $314 |
| Innovation Technologies Inc | 2 | $153 |
| Medical Device Business Services, Inc. | 1 | $138 |
| Conmed Corporation | 2 | $113 |
| Davol Inc. | 1 | $102 |
| Johnson & Johnson | 1 | $31 |
| BD | 1 | $28 |
| Smith+Nephew | 1 | $26 |
| Misonix Inc | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$11,300
- DAVINCI XI$1,000
- PerClot$314
- Signet$143
- Enseal$138
- Signia$106
- PHASIX$102
How this compares
$15,361 in reported general payments places this provider in the 85th percentile of 79 colon & rectal surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 12 | $172 |
| Neomycin Sulfate | 33 | $97 |
| LoperamideLoperamide Hcl | 12 | $89 |
| Metronidazole | 36 | $84 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $56 |
| Prochlorperazine Maleate | 25 | $31 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Elmwood Park
- Marc SingerChicago$201K
- Francisco QuinterosChicago$119K
- Lawrence PrabhakerRockford$81K
- Konstantin UmanskiyChicago$30K
- Vitaliy PoylinChicago$26K
- Monika KrezalekHighland Park$23K
- Jeremy SugrueNaperville$22K
- Neil HymanChicago$20K
- Amy HalversonChicago$19K
- Gerald GanttChicago$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.